Quiz intensiv – stellen Sie die Diagnose!

Ein 67-jähriger Patient wird 7 Tage nach erfolgter Bypass-OP kaltschweißig mit Dyspnoe und Tachypnoe auf der Normalstation aufgefunden. Er wird sofort auf die Intensivstation übernommen.

Fragen

• Welche Diagnose ist am wahrscheinlichsten?

• Welche Differenzialdiagnosen müssen in Betracht gezogen werden?

• Wie wird therapeutisch vorgegangen?

Publication History

Article published online:
23 March 2023

• Literatur

• 1 Hale PJ, Crase J, Nattrass M. Metabolic effects of bicarbonate in the treatment of diabetic ketoacidosis. Br Med J (Clin Res Ed) 1984; 289: 1035-1038 DOI: 10.1136/bmj.289.6451.1035. (PMID: 6091840)
• 2 Chua HR, Schneider A, Bellomo R. Bicarbonate in diabetic ketoacidosis – a systematic review. Ann Intensive Care 2011; 1: 23 DOI: 10.1186/2110-5820-1-23. (PMID: 21906367)
• 3 Morris LR, Murphy MB, Kitabchi AE. Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med 1986; 105: 836-840 DOI: 10.7326/0003-4819-105-6-836. (PMID: 3096181)
• 4 Viallon A, Zeni F, Lafond P. et al. Does bicarbonate therapy improve the management of severe diabetic ketoacidosis?. Crit Care Med 1999; 27: 2690-2693 DOI: 10.1097/00003246-199912000-00014.
• 5 Kitabchi AE, Umpierrez GE, Miles JM. et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009; 32: 1335-1343 DOI: 10.2337/dc09-9032.
• 6 Blau JE, Tella SH, Taylor SI. et al. Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data. Diabetes Metab Res Rev 2017; 33 DOI: 10.1002/dmrr.2924.
• 7 Burke KR, Schumacher CA, Harpe SE. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature. Pharmacotherapy 2017; 37: 187-194 DOI: 10.1002/phar.1881. (PMID: 27931088)
• 8 Ferrannini E, Muscelli E, Frascerra S. et al. Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. J Clin Invest 2014; 124: 499-508 DOI: 10.1172/JCI72227. (PMID: 24463454)
• 9 Foster DW. Malonyl-CoA: the regulator of fatty acid synthesis and oxidation. J Clin Invest 2012; 122: 1958-1959 DOI: 10.1172/jci63967. (PMID: 22833869)
• 10 Merovci A, Solis-Herrera C, Daniele G. et al. Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production. J Clin Invest 2014; 124: 509-514 DOI: 10.1172/JCI70704. (PMID: 24463448)
• 11 Plewa MC, Bryant M, King-Thiele R. Euglycemic Diabetic Ketoacidosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022
• 12 Kraut JA, Madias NE. Treatment of acute metabolic acidosis: a pathophysiologic approach. Nat Rev Nephrol 2012; 8: 589-601 DOI: 10.1038/nrneph.2012.186. (PMID: 22945490)
• 13 Mitchell JH, Wildenthal K, Johnson jr RL. The effects of acid-base disturbances on cardiovascular and pulmonary function. Kidney Int 1972; 1: 375-389 DOI: 10.1038/ki.1972.48. (PMID: 4599247)
• 14 Deutsche Diabetes Gesellschaft (DDG). et al. S3-Leitlinie Therapie des Typ-1-Diabetes. AWMF-Registernr. 057–013. 28.03.2018 Accessed June 22, 2022 at: https://register.awmf.org/de/leitlinien/detail/057–013
• 15 Nyenwe EA, Kitabchi AE. The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management. Metabolism 2016; 65: 507-521 DOI: 10.1016/j.metabol.2015.12.007. (PMID: 26975543)
• 16 Hishida Y, Nakamura Y, Tsukiyama H. et al. A retrospective cohort study for the treatment of Asian diabetic ketoacidosis: optimizing initial doses of insulin. Acute Med Surg 2021; 8: e721 DOI: 10.1002/ams2.721. (PMID: 34976402)
• 17 Kitabchi AE, Ayyagari V, Guerra SM. The efficacy of low-dose versus conventional therapy of insulin for treatment of diabetic ketoacidosis. Ann Intern Med 1976; 84: 633-638 DOI: 10.7326/0003-4819-84-6-633. (PMID: 820228)
• 18 Page MM, Alberti KG, Greenwood R. et al. Treatment of diabetic coma with continuous low-dose infusion of insulin. Br Med J 1974; 2: 687-690 DOI: 10.1136/bmj.2.5921.687.